Diagnostics

Infectech engages Lake Erie Research Institute for FDA submissions

Published in Medical Letter on the CDC and FDA, December 26th, 2004

Nutra Pharma Corp. (OTCBB:NPHC) announced that its holding, Infectech, Inc., (Pink Sheets:IFEC) has engaged Lake Erie Research Institute, Inc., (LERI) to assist in all U.S. Food and Drug Administration (FDA) device and 510K submissions required for the company to begin commercializing its Identikit technology.

The company anticipates filing their first documentation before the end of the year.

The Lake Erie Research Institute provides wrap-around research services, such as protocol development, statistical analysis, grant writing, business plan development, technology transfer, and other needed expertise. They are being contracted by Infectech to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2004-12-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry